Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Loyola University
Lidocaine-prilocaine (EMLA 5%) cream has been shown to be effective in reducing pain during minor gynecologic procedures. The primary objective of this trial is to determine if the use of 5% EMLA cream at the time of pessary removal and insertion reduces pain when compared to the use of placebo cream.
Participants will be randomized to receive either 10 grams of 5% EMLA cream (4 mL) or 4 mL of placebo cream (aqueous cream BP). Cream will be applied in office at the time of pessary removal and insertion.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women in the Loyola Urogynecology clinic who use a pessary for management of pelvic organ prolapse (POP) or urinary incontinence (UI)
Read and speak the English language
You may not be if
Non-English speaking
Allergy or contraindication to topical anesthetic
Participation/randomization in the study at a previous visit
Currently pregnant or lactating or planning a pregnancy within the next 6 months
